2 ml vial of tirzepatide Eli Lilly Launches Self-Pay Vials for Patients With Obesity Tirzepatide Instructions | Allure Medical

Not everyone needs to reach 15mg to achieve their goals

Medicaid in Connecticut also does not cover the drugs for weight loss

Safety outcomes included the incidence of hypoglycemia, acute pancreatitis, acute renal failure, malignant neoplasms, gastrointestinal adverse events (e.g., nausea, vomiting, diarrhoea, and constipation), and all-cause death

Trial participants who weighed between 230 and 265 pounds lost an average of between 35 and 45 pounds in 68 weeks

Biochemistry 45 (11), 36843691

Many individuals with BED also present with comorbid obesity, type 2 diabetes, depression, or anxiety disorders, complicating treatment approaches